c-MET Immunohistochemistry For Differentiating Malignant Mesothelioma from Benign Mesothelial Proliferations.
Sign Up to like & getrecommendations! Published in 2020 at "Human pathology"
DOI: 10.1016/j.humpath.2020.08.010
Abstract: The separation of benign from malignant mesothelial proliferations can be a difficult problem for the surgical pathologist. c-MET is a receptor tyrosine kinase that is overexpressed and detectable by immunohistochemistry in many malignancies, including malignant… read more here.
Keywords: immunohistochemistry; mesothelial proliferations; score; benign mesothelial ... See more keywords